Personalis (PSNL) s Beating the Odds – And It Could Beat Cancer Too
Personalis Inc. (NASDAQ:PSNL) is a pioneering company in the field of precision oncology and advanced genomics, dedicated to…
Emergent BioSolutions (EBS) Could Keep Sinking Despite New Contracts
Emergent BioSolutions Inc. (NYSE:EBS) is a global life sciences company headquartered in Gaithersburg, Maryland, with a long-standing mission…
HealthEquity (HQY) Crushes Earnings With 67% Profit Surge
HealthEquity, Inc. (NASDAQ:HQY) is the largest independent custodian of Health Savings Accounts (HSAs) in the United States, playing…
Beam Therapeutics (BEAM) is Oversold & Ready to Explode Higher
Beam Therapeutics Inc. (NASDAQ:BEAM) is a biotechnology company at the forefront of developing precision genetic medicines through its…
TG Therapeutics (TGTX) Can Be the Next $1B Biotech Giant
TG Therapeutics Inc. (NASDAQ:TGTX) is a fully integrated biopharmaceutical company dedicated to developing and delivering transformative therapies for…
Molina Healthcare (MOH)’s Medicaid Empire Faces Its Toughest Test Yet
Molina Healthcare, Inc. (NYSE:MOH) is a Fortune 500 managed care company founded in 1980 by Dr. C. David…
Phathom Pharma (PHAT)’s Future Hangs on a Single Pill
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) is a biopharmaceutical company headquartered in Florham Park, New Jersey, focused on the development…
Analysts Predict Over 100% Upside by 2026 for Crinetics Pharma (CRNX)
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is a San Diego-based clinical-stage pharmaceutical company dedicated to the discovery, development, and…
Wall Street Predicts 130%+ Upside for Serina Therapeutics (SER)
Serina Therapeutics, Inc. (NYSE:SER) is a clinical-stage biotechnology company headquartered at the HudsonAlpha Institute of Biotechnology in Huntsville,…
Aligos Therapeutics (ALGS) Doubles Cash to $122.9M
Aligos Therapeutics Inc. (NASDAQ:ALGS) is a clinical-stage biopharmaceutical company based in South San Francisco, California, that is focused…
$450M Deal With Merck Could Supercharge Neuphoria Therapeutics (NEUP)
Neuphoria Therapeutics Inc. (NASDAQ:NEUP) is a clinical-stage biotechnology company dedicated to developing innovative treatments for neuropsychiatric disorders that…
MEI Pharma (MEIP) Shocks Wall Street With $100M Litecoin Bet
MEI Pharma Inc. (NASDAQ:MEIP) is a San Diego-based clinical-stage pharmaceutical company that has built its identity around the…
Stoke Therapeutics (STOK) Soars but Hidden Risks Could Trigger a Sell-Off
Stoke Therapeutics Inc. (NASDAQ:STOK)is a clinical-stage biopharmaceutical company founded in 2014 and headquartered in Bedford, Massachusetts, with a…
Generation Bio (GBIO) Has $185M in Cash—Here’s Why That Matters
Generation Bio Co. (NASDAQ:GBIO) is a biotechnology company pioneering a new class of genetic medicines designed to expand…
Radiopharm (RADX) Stock: High Risk, High Hype
Radiopharm Theranostics Ltd. (NASDAQ:RADX) is a clinical-stage biotechnology company focused on the development and commercialization of radiopharmaceutical products…
Salarius Pharmaceuticals (SLRX) Merger Won’t Save it From Trouble
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) is a clinical-stage biopharmaceutical company incorporated in Delaware and headquartered in Houston, Texas. The…
Titan Pharmaceuticals (TTNP) Merger Hype vs. Reality
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) is a biopharmaceutical company that has spent decades focused on the development and commercialization…
HCA Healthcare (HCA) Surges Over 228% Since 2019
HCA Healthcare Inc. (NYSE:HCA) is one of the largest healthcare providers in the United States and a leading…